$3.36
-0.07 (-2.04%)
Open$3.34
Previous Close$3.43
Day High$3.54
Day Low$3.34
52W High$30.80
52W Low$1.83
Volume—
Avg Volume29.3K
Market Cap18.33M
P/E Ratio—
EPS$-5.27
SectorBiotechnology
Analyst Ratings
Strong Sell
6 analysts
Price Target
+1,107.4% upside
Current
$3.36
$3.36
Target
$40.57
$40.57
$36.99
$40.57 avg
$64.99
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 5.39M | 5.45M | 4.30M |
| Net Income | -1,299,864 | -1,279,500 | -760,803 |
| Profit Margin | -24.1% | -23.5% | -17.7% |
| EBITDA | -1,608,718 | -1,854,994 | -1,475,925 |
| Free Cash Flow | -1,268,218 | -1,023,573 | -724,682 |
| Rev Growth | -8.0% | -5.0% | +17.9% |
| Debt/Equity | 0.74 | 0.71 | 0.67 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |